Delivery Order 36C26324D0043-36C26326N0201
- Not listed
- The U.S. Department of Veterans Affairs (VA) awarded a $36,295.60 firm fixed-price delivery order contract to Denver Solutions, LLC, a for-profit limited liability company, to provide 503B compounded sterile pharmaceutical products to federal healthcare agencies. The contract has no set-aside designation and is valid through September 30, 2024. Denver Solutions specializes in providing specialized injectable medications, sterile compound kits, and liquid-filled implantable drug delivery...
- This federal contract award, with an ID of 36C26324D0043|36C26325N0139, was made by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency within the Department of Veterans Affairs (VA). The $131,000.00 contract was awarded to Denver Solutions, LLC, a for-profit limited liability company, to provide 503B compounded sterile pharmaceutical products to federal healthcare agencies, primarily the VA and Defense Health Agency. The contract is a firm fixed-price delivery order with...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, an FDA-registered 503B outsourcing provider. The $97,431.43 contract is for the delivery of sterile compound products, including injectables like ropivacaine, ketamine, phenylephrine, and ephedrine, as well as sterile compound kits and LEITERS (liquid-filled implantable drug delivery systems). The contract is not set-aside and runs through September 30, 2022. In...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, a for-profit limited liability company. The $332,684.50 contract is for the delivery of LEITERS (liquid-filled implantable drug delivery systems) to support VA medical facilities in the Minneapolis area. The delivery order is part of a larger $786,527 indefinite delivery contract (IDC) from May 2022 through September 2023 for Denver Solutions to provide LEITERS to VA...
- Denver Solutions, LLC has been awarded a firm fixed-price purchase order totaling $40,498.10 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The award is for ropivacaine hydrochloride injection to support medical centers in Palo Alto, California, with no set-aside designation applied. Denver Solutions will supply the pharmaceutical requested under the original solicitation as the prime contractor. Additionally, Denver Solutions holds...
- This federal contract award is for the provision of 503B compounding pharmaceuticals to the Veterans Integrated Service Network 23 (VISN 23), which is part of the U.S. Department of Veterans Affairs (VA). The prime contractor, Wells Pharma of Houston LLC, is a for-profit limited liability company specializing in pharmaceutical manufacturing and distribution for federal healthcare agencies. The contract has a ceiling value of $50,148.50 and a period of performance through March 31, 2026. It is...
- Denver Solutions, LLC was awarded a $250,000 firm fixed price purchase order by the Defense Health Agency to provide various 503B compounded injectable pharmaceuticals. The place of performance is Greenwood Village, Colorado. The contract has a two year period of performance from July 2020 through July 2022. This requirement was set aside for total small businesses. Per the original solicitation from the Naval Supply Systems Command, the awarded contract supports the delivery of over 50...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government, specifically the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $88,903.68 and was awarded on February 18, 2020, with a completion date of February 19, 2020. The contract is a Delivery Order under an...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government, specifically to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The prime contractor is Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract, valued at $1,566.68, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government, primarily the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The contract, valued at $2,250.90, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- 36C26324D0043Indefinite Delivery Contract
- 36C26324D0043-36C26326N0201Delivery Order
This federal contract award is for a 503B compounding facility to provide pharmaceuticals to the U.S. Department of Veterans Affairs (VA). The prime contractor is Denver Solutions, LLC, a for-profit limited liability company registered in SAM.gov that specializes in 503B compounded sterile pharmaceutical products for federal healthcare agencies. The contract is a delivery order with a firm fixed price of $48,500.00 and a period of performance through March 31, 2026. Denver Solutions has established a relationship with the VA, holding two significant Indefinite Delivery Contracts (IDCs) valued at $786,527.88 and $173,000 for LEITERS (liquid-filled implantable drug delivery systems) and 503B compounded sterile pharmaceutical preparations, respectively. The contract does not have a set-aside designation. The awarded pharmaceuticals are likely to support healthcare services for veterans through the VA's Veterans Integrated Service Network (VISN) 23.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.5k | 10/1/25 |